Peroxisome proliferators are a group of structurally diverse chemicals that cause the proliferation of peroxisomes in rodents. The purpose of this investigation was to test the hypothesis that the shared effect of these compounds on peroxisome proliferation is mediated through a common inhibitory effect on mitochondrial bioenergetics. Freshly isolated rat liver mitochondria were energized with succinate. The effect of the chemicals on mitochondrial bioenergetics was analyzed by monitoring calcium-induced changes in membrane potential and swelling, as well as changes in mitochondrial respiration. Mitochondrial membrane potential was measured with a TPP ؉ -sensitive electrode, and swelling was recorded spectrophotometrically. Mitochondrial oxygen uptake was monitored with a Clark-type oxygen electrode. Gemfibrozil and WY-14,643 induced the mitochondrial permeability transition as characterized by calcium-induced swelling and depolarization of membrane potential, both of which were inhibited by cyclosporine A. Fenofibrate, clofibrate, ciprofibrate and diethylhexyl phthalate, on the other hand, caused a direct dose-dependent depolarization of mitochondrial membrane potential. However, the mechanism of membrane depolarization varied among the test chemicals. Bezafibrate and trichloroethylene elicited no effect on succinate-supported mitochondrial bioenergetics. The results of this investigation demonstrate that although most, but not all, peroxisome proliferators interfere with mitochondrial bioenergetics, the specific biomolecular mechanism differs among the individual compounds.
Peroxisome proliferators are a broad class of structurally diverse chemicals that includes fibric acid hypolipidemic drugs, phenoxy herbicides, phthalate plasticizers, and many other industrial solvents. In rodents, these chemicals cause a dramatic increase in both the size and number of peroxisomes, which is accompanied by proportionate increases in the activities of several enzymes associated with peroxisomal fatty acid ␤-oxidation (Reddy and Azarnoff, 1980; Lalwani et al., 1983) . The mechanism(s) by which these compounds induce peroxisome proliferation, however, remains unclear. A general theory is that these agents induce the proliferation of peroxisomes, and possibly tumorigenesis (Ashby et al., 1994) , via interaction of the compound, or a metabolite, with specific nuclear-located, peroxisome proliferator-activated receptor ␣ (PPAR␣). A heterodimer of PPAR and retinoid X receptor interacts with specific response elements to promote the transcription of a battery of peroxisome-specific genes downstream from the promoter. Whether cell cycle-specific genes are subject to the same regulatory element remains to be conclusively defined.
It is possible that ligands other than the particular peroxisome proliferator or its metabolite might also interact with PPAR␣ to induce gene transcription. For example, the ligand may be a metabolite of early events preceding the activation of PPAR␣. In particular, because of the complementary role of peroxisomes and mitochondria in beta-oxidation (Bojes et al., 1996; Masters and Crane, 1984) , we considered the possibility that peroxisome proliferation may be a consequence of inhibition of mitochondrial fatty-acid oxidation. There are many reports documenting that mitochondria are affected by exposures to peroxisome proliferators. Lundgren et al. (1990) reported that mitochondria decrease in size in the livers of mice treated with clofibrate, nafenopin or WY-14,643, while a moderate increase in the number of hepatic mitochondrial profiles was observed. Furthermore, inhibition of the mitochondrial respiratory chain at the level of cytochrome c reductase was suggested as an early step in the mechanism by which phthalate esters cause hepatic peroxisome proliferation (Winberg and Badr, 1995) . Other studies have demonstrated that the peroxisome proliferator WY-14,643 uncouples oxidative phosphorylation in vitro as well as in vivo (Keller et al., 1993 (Keller et al., , 1992 . The uncoupling of cellular respiration may reduce the ATP supply and inhibit energy-dependent acyl-CoA synthetase activity indirectly.
Two chemical characteristics shared by most peroxisome proliferators are their strong lipophilicity, and the presence of either a carboxylic acid functional group or a group that can be readily oxidized to carboxylic acid. It is well known that weak acids comprise one of several classes of agents capable of inducing the mitochondrial permeability transition in vitro (Gunter and Pfeiffer, 1990) . Opening of this pore results in the dissipation of transmembrane ionic gradients, resulting in depolarization of membrane potential, inhibition of oxidative phosphorylation, and high-amplitude mitochondrial swelling, all of which are implicated in the mechanism of cytotoxicity of numerous agents (Kass et al., 1992; Nieminen et al., 1995) .
Irrespective of the specific molecular mechanisms, each of these interfering effects of peroxisome proliferators on mitochondrial bioenergetics leads to an inhibition of ATP production, which in turn may trigger peroxisome proliferation and interruption of critical control points in cell turnover. This deficit of ATP, or some other biochemical indicator of metabolic dysfunction, may directly or indirectly signal the activation of PPAR␣. It was the purpose of this investigation to determine whether all peroxisome proliferators interfere with mitochondrial bioenergetics, and if it is by the same biomolecular mechanism. If so, mitochondrial dysfunction may serve as a common final pathway for signaling the necessary molecular events leading to peroxisome proliferation.
MATERIALS AND METHODS
Chemicals. Gemfibrozil, clofibrate, bezafibrate, fenofibrate, ciprofibrate, di(2-ethylhexyl) phthalate (DEHP) and trichloroethylene (TCE) were purchased from Sigma Chemical Co. (St. Louis, MO). WY-14,643 was purchased from Chemsyn Science Laboratories (Lenexa, KS). All peroxisome-proliferating chemicals were dissolved in ethanol, aiming for a final ethanol concentration in the reaction medium of less than 1%, which would not alter any of the parameters measured. Cyclosporine A (CyA) was a generous gift from Sandoz Pharmaceutical Corp. (East Hanover, NJ).
Isolation of rat liver mitochondria. Hepatic mitochondria were isolated from adult male Sprague-Dawley rats (200 -300 g) by differential centrifugation . Rats were purchased from Harlan SpragueDawley (Madison, WI) and acclimated in an AAALAC-accredited, climatecontrolled (21°C; 14/10 h light cycle) animal-care facility for at least 3 days and fasted the night before the experiment. Animals were killed by decapitation and the livers quickly homogenized (teflon:glass pestle) in 8 vol. (ml/g) of cold 210 mM mannitol-70 mM sucrose-1 mM HEPES (pH 7.4) solution. The homogenate was centrifuged for 10 min. at 700 g and 4°C, and the mitochondria recovered from the supernatant by centrifugation at 12,000 g for 10 min. The mitochondrial pellet was washed twice before resuspending the final pellet in 210 mM mannitol-70 mM sucrose-5 mM HEPES (pH 7.4) at a protein concentration of 25-30 mg/ml. Membrane potential. Mitochondrial membrane potential (⌬) was estimated using an ion-selective electrode to measure the distribution of tetraphenylphosphonium ion (TPP ϩ ), according to previously established methods (Kamo et al., 1979; Palmeira et al., 1994) . The reference electrode was HgCl 2 . Mitochondria (1 mg/ml) were suspended, with constant stirring, at 30°C in 200 mM sucrose-10 mM Tris-MOPS (pH 7.4)-1 mM KH 2 PO 4 -10 M EGTA, supplemented with 2 M rotenone and 1 g/ml oligomycin. TPP ϩ was added to a final concentration of 4 M and the mitochondria energized by adding succinate to a final concentration 5 mM. The distribution of TPP ϩ was allowed to reach a new equilibrium before making any further additions. The TPP ϩ electrode was calibrated assuming Nerstian distribution of the ion across the synthetic membrane, and ⌬ is expressed as mV.
Mitochondrial swelling. Changes in mitochondrial volume were estimated by changes in light scattering, as monitored spectrophotometrically at 540 nm Palmeira and Wallace, 1997) . Mitochondria were suspended at 1.0 mg protein/ml in 200 mM sucrose-10 mM Tris-MOPS (pH 7.4)-1 mM KH 2 PO 4 -10 M EGTA supplemented with 2 M rotenone and 1 g/ml oligomycin. The reaction was stirred continuously and the temperature maintained at 30°C. The mitochondria were energized with 5 mM succinate for 1.0 min. before adding gemfibrozil, clofibrate, bezafibrate, ciprofibrate, WY-14,643, fenofibrate, DEHP, or TCE. CaCl 2 was added 1.0 min. later. Where indicated, cyclosporine A was added just prior to succinate. None of the reagents interfered with the spectrophotometric analysis.
Mitochondrial oxygen consumption.
Mitochondria were suspended at a concentration of 1 mg/ml in 200 mM sucrose-10 mM Tris-MOPS (pH 7.4)-1 mM KH 2 PO 4 -10 M EGTA, supplemented with 2 M rotenone. The incubations were conducted at 30 0 C in a closed reaction chamber with constant stirring. Oxygen concentration was monitored continuously, employing a Clark-type oxygen electrode.
The reactions were initiated by adding succinate to a final concentration of 5 mM. Non-phosphorylating, state-4 respiration was monitored for at least 3 min prior to adding ADP to initiate state-3 respiration. Oxygen tension was then monitored continuously until state 4 respiration was resumed, at which point the desired peroxisome proliferator compound was added followed by ADP, and the recording of respiratory control index (RCI) and ADP/O was repeated. Paired statistical comparisons were made between the RCI or ADP/O, recorded before (control) and after adding the test compound.
Protein content. Protein concentration was determined by the Bradford protein assay. Bovine serum albumin served as the protein standard.
Statistical analysis.
Values are presented as means Ϯ SEM. Statistical comparisons were performed using paired StudentЈs t-test. A probability of p Ͻ 0.05 served as the criterion for statistical significance.
RESULTS

Calcium-Dependent Mitochondrial Swelling Caused by Gemfibrozil and WY-14,643
Mitochondria possess a finite capacity for accumulating calcium before undergoing the calcium-dependent mitochondrial permeability transition. This is illustrated in Figure 1 , where calcium was added at increasing concentrations to mitochondria that had been energized with succinate in the presence of 2 M rotenone. Twenty-five M CaCl 2 (25 nmol/mg protein) caused minimal mitochondrial swelling, whereas Ͼ50 M calcium concentration caused a dose-related increase in the rate, but not the extent, of swelling. Based on these results, a calcium concentration of 50 M was chosen as a standard FIG. 1. Calcium-dependent induction of the mitochondrial permeability transition. Rat liver mitochondria were incubated at 1 mg protein/ml in 200 mM sucrose-10 mM Tris-MOPS (pH 7.4)-1 mM KH 2 PO 4 -10 M EGTA supplemented with 2 M rotenone and 1 g/ml oligomycin. The reaction was stirred continuously and the temperature maintained at 30 0 C. The mitochondria were energized with 5 mM succinate for 2 min. before adding CaCl 2 at the indicated concentrations. Light scattering was monitored continuously at 540 nm and served as the basis for assessing changes in mitochondrial volume. against which to assess the effect of gemfibrozil, WY-14,643, fenofibrate, clofibrate, bezafibrate, ciprofibrate, TCE and DEHP.
Adding gemfibrozil to succinate-energized rat liver mitochondria followed by 50 M calcium (50 nmol calcium/mg protein) caused a dose-dependent stimulation of mitochondrial swelling (Fig. 2) . The induction of mitochondrial swelling by gemfibrozil exhibited delayed kinetics. Once initiated, however, the mitochondria in suspension underwent the same magnitude of volume change, regardless of the concentration of gemfibrozil. This suggests that the induction of mitochondrial swelling was complete and that the effect of gemfibrozil was to alter the time-constant preceding activation of the permeability transition pore. The induction of the mitochondrial permeability transition by gemfibrozil was evidenced by the fact that adding 0.85 M CyA just prior to gemfibrozil completely prevented the calcium-induced mitochondrial swelling. The degree of swelling, which was essentially zero, was substantially less than that observed for controls, in the presence of 50 M calcium but in the absence of gemfibrozil.
The mitochondrial permeability transition induced by WY-14,643 is illustrated in Figure 3 . Like gemfibrozil, WY-14,643 induced mitochondrial swelling, which exhibited delayed kinetics. Regardless of the concentration of WY-14,643, the mitochondria in suspension underwent the same magnitude of volume change, which suggested complete mitochondrial swelling. The implication of induction of the mitochondrial permeability transition by WY-14,643 was gained from the effect of CyA. Incubation of isolated mitochondria with 50 M calcium plus 0.2 mM WY-14,643 caused a rapid and profound decrease in light scattering. Adding 0.85 M CyA to this incubation completely prevented the calcium-induced mitochondrial swelling caused by WY-14,643.
Calcium-Dependent Membrane Depolarization Induced by
Gemfibrozil and WY-14,643 Figure 4 illustrates the effects of gemfibrozil and WY-14,643 on mitochondrial membrane potential. Mitochondria at 1 mg protein/ml were energized with succinate. Calcium at 50 M (50 nmoles/mg protein) caused an immediate, yet transient, depolarization of mitochondrial membrane potential. In the presence of gemfibrozil or WY-14,643 in the reaction medium, 50 M calcium caused a dramatic and irreversible depolarization. Adding 0.85 CyA prior to succinate completely inhibited the effects of gemfibrozil and WY-14,643 on membrane depolarization. Gemfibrozil and WY-14,643 also caused a dose-dependent suppression of the membrane potential. At 75-100 nmol/mg, the direct membrane depolarization caused by gemfibrozil and WY-14,643 was more than could be attributed to ethanol, but of minor significance to the overall mitochondrial bioenergetics. Fenofibrate, clofibrate, ciprofibrate, bezafibrate, TCE, and DEHP had no effect on the calciumdependent induction of the mitochondrial permeability transition (data not shown).
Direct Depolarization of Mitochondrial Membrane Potential
Caused by Fenofibrate, Clofibrate, Ciprofibrate, and DEHP Fenofibrate, clofibrate, ciprofibrate, and DEHP directly depress mitochondrial membrane potential (Fig. 5) . The direct depolarization by each of these four agents was dose-dependent. Fenofibrate, at 50 M, caused complete depolarization of mitochondrial membrane potential, adding 2,4-dinitrophenol (DNP) caused no further depolarization (data not shown). Seventy-five M fenofibrate caused no greater depolarization than was observed for 50 M. Clofibrate completely depolarized the mitochondrial membrane potential at a concentration of 300 M; further depolarization by adding DNP was not possible. The depolarization caused by ciprofibrate was also immediate and dose-dependent. DEHP, on the other hand, 
The Effects of Gemfibrozil, WY-14,643, Clofibrate, Ciprofibrate, DEHP, and Fenofibrate on Mitochondrial Respiration
The determination of the effects of these agents on mitochondrial respiration was conducted in a closed reaction chamber. The effects of gemfibrozil, WY-14,643, clofibrate, ciprofibrate, and DEHP on respiratory control index (RCI) of mitochondria are illustrated in Figure 6a . The RCI is a measure of the dependence of the respiratory rate on ADP, and is determined by the ratio of state-3 to state-4 respiration. All of these compounds caused a decreased RCI as compared to control, largely attributed to the stimulation of state-4 respiration by gemfibrozil, WY-14,643, clofibrate, and ciprofibrate. In contrast, the decrease in the RCI for DEHP, which was not statistically significant, was due to the decrease in state-3 respiration (data not presented). The effect of gemfibrozil, WY-14,643, clofibrate, ciprofibrate, and DEHP on mitochondrial ADP/O ratio is illustrated in Fig. 6 b. ADP/O is a measure of the efficiency of mitochondrial oxidative phosphorylation. All of these compounds significantly impaired mitochondrial oxidative phosphorylation, which is in good agreement with previously published observations (Keller et al., 1992) . Fenofibrate, in contrast, exhibited a different effect on the mitochondrial respiration (Fig. 7) . At 75 M fenofibrate inhibited both state-3 and state-4 respiration, but did not alter the rate of uncoupled respiration, indicating that fenofibrate does not in -FIG. 4 . Effects of gemfibrozil and WY-14,643 on the mitochondrial membrane potential. Freshly isolated rat liver mitochondria were incubated at 37°C in a reaction chamber, at 1 mg protein/ml in 200 mM sucrose-10 mM Tris-MOPS (pH 7.4)-1 mM KH 2 PO 4 -10 M EGTA supplemented with 2 M rotenone and 1 g/ml oligomycin. Final volume was 1 ml. The experiments were started by adding 5 mM succinate, followed by gemfibrozil or WY-14,643 at the indicated concentrations. After mitochondrial membrane potential had been reestablished, 50 M CaCl 2 was added. Where indicated, 0.85 M CyA was added at the beginning of the reaction, 1 min prior to succinate. The traces represent typical direct recordings from several independent experiments with different mitochondrial preparations.
hibit the electron transport chain, ATPase activity, or the adenine nucleotide translocase. Neither 200 M bezafibrate nor TCE influenced mitochondrial respiration.
DISCUSSION
There are a number of structurally diverse compounds that cause peroxisome proliferation in rodents (Reddy and Azarnoff, 1980; Lalwani et al., 1983) , however the mechanisms underlying this response remain unclear. In this investigation, we tested the hypothesis that the response to these compounds is mediated through a common effect on mitochondrial bioenergetics. Selected peroxisome proliferators have previously been shown to alter mitochondrial respiration; WY-14,643 uncouples oxidative phosphorylation (Keller et al, 1992 (Keller et al, , 1993 and phthalates inhibit mitochondrial ␤-oxidation (Winberg and Badr, 1995) . Both effects lead to inhibition of ATP synthesis and the accumulation of unsaturated fatty acids in cytosol, which may serve to signal stimulation of cell turnover and peroxisome proliferation. The accumulation of intracellular fatty acids likely reflects the combined effects of PPAR␣-stimulated expression of lipoprotein lipase and inhibition of mitochondrial ␤-oxidation. Whether all peroxisome proliferators inhibit mitochondrial function, however, is unknown. Furthermore, it has yet to be determined if those proliferators which interfere with mitochondrial bioenergetics all act through a common molecular mechanism.
In the present investigation, gemfibrozil and WY-14,643 were found to induce the mitochondrial permeability transition pore, as reflected by their stimulation of Ca 2ϩ -dependent swelling and depolarization of mitochondrial potential. CyA, which is a specific and potent inhibitor of the permeability transition pore (Broekemeier et al., 1989) , completely protected against the Ca 2ϩ -dependent swelling and membrane depolarization. Induction of the permeability transition not only results in rapid dissipation of electrochemical gradients, it is also associated with the release of small molecular weight solutes including calcium and GSH (Custodio et al., 1998; Savage et al., 1991; Savage and Reed, 1994; Solem and Wallace, 1993) . The released Ca 2ϩ may contribute to increasing intracellular Ca 2ϩ , which serves as a second messenger in the signal transduction pathway implicated in stimulating cell proliferation (Kaneko et al., 1992; Watanabe et al., 1994) . Moreover, it has been suggested that the mitogenic response to the peroxisome proliferator ciprofibrate is manifest through the inhibition of endoplasmic reticulum Ca 2ϩ -ATPase and an increase in cytosolic calcium (Bennett and Williams, 1992) . Keller et al. (1992) suggest that uncoupling of oxidative phosphorylation by WY-14,643 may account for the stimulation of cell turnover and peroxisome proliferation. Accordingly, induction of mitochondrial permeability transition by gemfibrozil and WY-14,643, and the associated inhibition of oxidative phosphorylation, may represent a common early step in the stimulation of peroxisome proliferation.
However, not all peroxisome proliferators were capable of inducing the mitochondrial permeability transition. Instead, clofibrate, ciprofibrate, DEHP, and fenofibrate all caused a direct depolarization of mitochondrial membrane potential, independent of the transition pore. The final event, however, was the same; mitochondrial membrane depolarization resulted in inhibition of ATP synthesis, which is implicated in the mechanism by which these compounds induce peroxisome proliferation (Keller et al., 1992) . However, membrane potential alone yields limited information on the specific molecular mechanism by which these agents interfere with mitochondrial function, since a number of factors contribute to the generation of the mitochondrial membrane potential. Indeed, these compounds exhibited distinct kinetics in causing mitochondrial membrane depolarization. Gemfibrozil, WY-14,643, clofibrate, and ciprofibrate decreased RCI by stimulating state-4 respiration, and reducing the ADP/O ratio. Thus, these compounds appear to act as uncouplers, which is consistent with the interpretation of Keller et al (1992) . Another related study by Chance and McIntosh (1995) demonstrated a dose-dependent reduction in RCI by clofibrate and gemfibrozil. In contrast, DEHP exhibited a different mechanism. State-4 respiration was not altered by DEHP. A similar result was obtained by Inouye et al. (1978) , who demonstrated that DEHP at 625 M reduced the rate of state-3 respiration. Therefore, the effect of DEHP on RCI and ADP/O cannot be explained by a nonspecific uncoupling effect on mitochondrial respiration. In- stead, DEHP may limit ADP transport by inhibiting the adenine nucleotide translocator (Kora et al., 1988) . Yet, the effect of DEHP is more than simply inhibition of the adenine nucleotide translocator since DEHP also depresses membrane potential directly. Winberg and Badr (1995) reported that monoethylhexylphthalate, a major metabolite of DEHP, inhibits mitochondrial respiration with both succinate and malate plus glutamate. Whether DEHP inhibits mitochondrial respiration directly or if this is attributed to a metabolite of DEHP remains to be determined.
Fenofibrate also caused a direct dose-dependent depolarization of mitochondrial membrane potential, but in a completely different fashion. Fenofibrate strongly inhibited both state-3 and state-4 respiration. However, fenofibrate did not influence the uncoupling effect of DNP. It appears, therefore, that fenofibrate may not inhibit critical components of either the electron transport chain, ATP synthetase or adenine nucleotide translocase. Regardless, the ultimate effect is the same, mitochondrial membrane depolarization and inhibition of oxidative phosphorylation. Bezafibrate and TCE at concentrations of up to 200 M, however, had no effect on mitochondrial membrane potential or Ca 2ϩ -dependent mitochondrial swelling. Recent research has implicated PPAR␣ in peroxisome proliferation, cell proliferation, and possibly tumor formation (Peters et al., 1997) . In the present study, it appears that peroxisome proliferators interfere with mitochondrial function through any of several mechanisms: inducing the permeability transition, depressing membrane potential, inhibiting the adenine nucleotide translocator, or inhibiting respiration directly. All these activities occur in isolated mitochondria and are obviously independent of PPAR␣. We postulate that interference with mitochondrial function represents an early event, perhaps preceding the activation of PPAR␣. Furthermore, mitochondrial dysfunction may participate in the activation of PPAR␣; it is possible that a metabolite of mitochondrial dysfunction may be a ligand for PPAR␣, providing an important metabolic link between the inhibition of mitochondrial fatty acid ␤-oxidation and stimulation of the corresponding peroxisomal enzymes (Bojes et al., 1996) .
In conclusion, we demonstrate that most, but not all, peroxisome proliferators interfere with succinate-supported mitochondrial bioenergetics. Whether bezafibrate and TCE inhibit the bioenergetics of mitochondria energized with substrates other than succinate remains to be determined. Alternatively, it might be suggested that metabolic activation is required to produce a metabolite of bezafibrate and/or TCE that is active in altering mitochondrial bioenergetics. The available evidence indicates that the fibric acid derivatives are active themselves but that both TCE and DEHP require metabolic activation in order to induce the proliferation of peroxisomes (Elcombe, 1985; Maronpot et al., 1995; Mitchell et al., 1985) . The monoethyl ester of DEHP (MEHP) has been shown to inhibit mitochondrial respiration at the level of cytochrome c reductase (Elcombe and Mitchell, 1986; Melnick and Schiller, 1985; Winberg and Badr, 1995) . Although trichloroacetic acid, which is the active metabolite of TCE, has not yet been studied in isolated mitochondria, it can be expected that at sufficiently high concentrations, this acid will cause nonspecific precipitation proteins.
Regardless, we must conclude that at toxicologically relevant concentrations, most but not all peroxisome proliferators alter mitochondrial bioenergetics. Furthermore, of those that do interfere with mitochondrial bioenergetics, several distinct mechanisms of inhibition of mitochondrial function by the different peroxisome proliferators were evident: (1) uncoupling of respiration and direct membrane depolarization (ciprofibrate, clofibrate), (2) induction of the mitochondrial permeability transition (gemfibrozil and WY-14,643), (3) possible inhibition of the adenine nucleotide translocation (DEHP), and (4) direct inhibition of mitochondrial respiration (fenofibrate). Although dissimilar in the specific biochemical mechanism, the ultimate effect is the same: inhibition of oxidative phosphorylation and ATP synthesis. The resulting accumulation of fatty acids has been implicated in triggering the proliferation of peroxisomes and the induction of peroxisomal fatty acyl CoA oxidase activity. Therefore, interference with mitochondrial bioenergetics may represent a final convergence of specific molecular events by which compounds of diverse chemical structure share a common final response of inducing the proliferation of peroxisomes in susceptible species. 
